Native Human Immunoglobulin G (IgG) Protein, Light Chain
Beta LifeScience
SKU/CAT #: BAR-0087P
Native Human Immunoglobulin G (IgG) Protein, Light Chain
Beta LifeScience
SKU/CAT #: BAR-0087P
Regular price$46500
$465.00
/
Submit an inquiry or email sales for a custom bulk quote. Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Description | The IgG light chain, comprising either kappa (κ) or lambda (λ) subtypes, is a 25 kDa polypeptide critical for antigen recognition and antibody diversity. Each light chain pairs with a heavy chain via disulfide bonds, forming the variable (VL) and constant (CL) domains that confer antigen-binding specificity and structural stability. In humans, κ and λ light chains maintain a serum ratio of ~2:1 for intact IgG, while free light chains (FLCs) exhibit a 1:1.5 ratio. Deviations from these ratios, particularly κ/λ FLC ratios <0.26 or >1.65, signal monoclonal proliferation in conditions like multiple myeloma or monoclonal gammopathy of undetermined significance (MGUS). Pathologically, misfolded IgG light chains drive AL amyloidosis, forming insoluble fibrils in organs such as the heart and kidneys, while non-fibrillar deposits in light chain deposition disease (LCDD) cause renal failure and hepatic dysfunction. Bence Jones proteins, urinary FLCs detected in 66% of myeloma cases, reflect clonal plasma cell activity. Elevated polyclonal FLCs also contribute to inflammatory diseases by activating mast cells and neutrophils. Clinically, serum FLC assays supersede urine tests for sensitivity in diagnosing oligosecretory myeloma and monitoring treatment response. Immunohistochemistry leveraging light chain restriction (κ or λ predominance) aids in differentiating reactive lymphoproliferations from B-cell lymphomas. |
| Source | Human Plasma |
| Form | Frozen |
| Buffer | Frozen in 20 mM sodium phosphate, pH 7.4, with 150 mM NaCl and 0.05% NaN₃ |
| Purity | Greater than 95% as determined by SDS-PAGE. |
| Molecular Weight | 23 kDa |
| Protein Determination | Extinction Coefficient (E) = 1.45 (0.1% at 280 nm, 1 cm pathway) |
| Storage/Handling | ≤ -20°C |

